Abstract. In contrast to normal liver, it is known that in vivo hepatomas fail to 
changes were also observed when binding and internalization were measured at 370C.
After HTC cells were incubated in lipid-depleted medium, the rate at which ['4C]acetate was incorporated into ['4C]cholesterol increased 2.5-fold. Inclusion of rat chylomicron remnants at 5-10 utg protein/ml prevented this increase in acetate incorporation or, if added after culture in lipid-depleted medium, reduced the increased levels back to control values. However, the rate of acetate incorporation into cholesterol by cells grown in complete medium was not decreased to levels below base line by rat chylomicron remnants. Inclusion of human LDL only partially prevented the rise or only partially reduced the increased levels back to control and did not reduce control levels below base line. Hypercholesterolemic VLDL, which contain more cholesterol per particle than chylomicron remnants, did reduce ['4C]acetate incorporation to below control levels. Therefore, the intracellular mechanism for down regulation of cholesterol synthesis by lipoproteins is intact in these cells.
Based on these results we hypothesized that a relative lack of lipoprotein receptors expressed by hepatomas in vivo in comparison with those expressed by normal liver would explain the apparent absence of feedback inhibition of cholesterol synthesis. Consistent with this hypothesis, the binding of chylomicron remnants to liver cell membranes was 3-5 times greater than to membranes from tumors grown in vivo subcutaneously or intramuscularly. Membranes from tumor cells grown in vitro bound remnants least well. It is proposed that the relative lack of receptors places the hepatoma at a disadvantage in competing with the liver for lipoproteins of dietary origin and may account for the lack of feedback regulation of cholesterol synthesis in hepatomas.
Introduction
The rate of cholesterol synthesis in normal liver is determined in part by the amount of cholesterol in the diet. When dietary cholesterol content increases, the rate of hepatic cholesterol biosynthesis decreases, and vice versa. This process is referred to as feedback regulation (1) . Dietary cholesterol is transported to the liver in lipoproteins that are called chylomicron remnants (2) (3) (4) . Current evidence suggests that the hepatocyte surface has a receptor that recognizes apolipoprotein E (5-8), which is an important constituent of the chylomicron remnant. After binding, the lipoprotein particle is degraded with hydrolysis of esterified lipid (3, 9-1 1) and, as with other cell types (12), the liberated free cholesterol then modulates the rate of cholesterol synthesis primarily at the level of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA)' reductase, which is the rate-limiting enzyme of cholesterol biosynthesis (13, 14) .
Siperstein ( 15) observed that the rate of cholesterol biosynthesis in Morris hepatomas grown subcutaneously in rats was not inhibited by increasing the amount of cholesterol in the diet. This was true for a large number of transplantable rat hepatomas (16), rat primary hepatocellular carcinomas (17) , and was also observed in human hepatomas (16). The defect in the tumors was independent of the basal rate of cholesterol biosynthesis, which ranged from levels higher than that of normal liver to <10% of the normal rate (15) . In addition, livers from rats treated with hepatic carcinogens also exhibited this abnormality of regulation even before malignant change was morphologically evident (18) .
Because the regulation of cholesterol biosynthesis is a multistep process, there are a number of potential sites at which such a defect could occur. Despite many investigations in the past, the defect has not yet been precisely identified. When HMG CoA reductase was partially purified from hepatoma cells and its physical and biochemical properties were compared with the enzyme from normal liver, no differences were found (19), which suggested that the enzyme per se is not altered to a major extent. Although it has been suggested that there is a defect in the coupling of cell cholesterol content to enzyme behavior in hepatomas, this change was seen in the host livers as well (20) . Mevalonolactone injected in vivo suppressed HMG CoA reductase in hepatomas (21) . Since the action of mevalonolactone depends at least in part upon its conversion to sterol, this suggested that the regulatory mechanism for HMG CoA reductase by sterols was functional. Furthermore, when hepatoma cells were grown in tissue culture (HTC 7288C), their reductase activity and their rate of sterol synthesis were decreased by the presence of 25-hydroxycholesterol or by high concentrations of low density lipoprotein (LDL) in the medium (22) . Reductase activity increased when these cells were cultured in the absence ofsterols. These observations further supported the concept that the intracellular mechanism of HMG-CoA reductase regulation was qualitatively intact.
Taken together, these studies suggested that the defect in feedback regulation relates to the delivery of cholesterol to the 1. Abbreviations used in this paper: HTC, hepatoma cells in tissue culture; HMG CoA, 3-hydroxy-3-methylglutaryl coenzyme A; LDM, lipid-depleted medium; PMSF, phenylmethylsulfonyl fluoride. site at which synthesis is regulated. Harry et al. (23) proposed this based on their observation that less intragastrically administered 3H-cholesterol was found in intramuscularly grown hepatomas than in the liver of the same rat. However, similar experiments with primary hepatomas showed only small differences in 3H-cholesterol uptake (17, 24) . Further, Bierne and Watson (25) observed that HTC cells that had shown regulation in vitro were no longer responsive to dietary cholesterol feedback when transplanted back in vivo. On the basis of these observations we hypothesized that a defect in the number or types of lipoprotein receptors expressed by hepatomas could account for the lack of feedback regulation in the tumor.
The purpose of the present investigation was to identify and examine the nature of the lipoprotein receptors present on the surface of HTC cells, to determine whether the receptors are regulated and whether they are capable oftransporting adequate amounts of cholesterol to initiate feedback inhibition of cholesterol biosynthesis, and finally to compare the numbers of receptors expressed in vivo by hepatomas and normal livers (26-28).
Methods
Materials. I-'4C-Acetic acid (sodium salt, 45-60 mCi/mmol) was purchased from New England Nuclear (Boston, MA), and 125I (15 Preparation of lipoproteins. Rat chylomicrons were collected from animals with a lymph duct cannula as described previously (31) . Chylomicron remnants were prepared in eviscerated rats as described previously (I 1, 32 (33) . The composition of the lipoproteins used in these studies has previously been reported by this laboratory (32, 34 (35) . The cell pellet was resuspended in 75 Al of PBS and layered onto 250 Ml of 100% calf serum which was contained in a siliconized 400-Ml microfuge tube. These tubes were centrifuged at 12,000 rpm for 5 min at 4VC and the supernatant was removed. The base ofthe tube containing the pellet was cut off and the radioactivity was determined in a gamma counter. The measured radioactivity was normalized to the number of cells per incubation, which was determined by counting the cells after the final resuspension at harvesting.
Lipoprotein degradation. HTC cells grown in complete medium (40 ml at 6 X 105 cells/ml) were harvested by centrifugation at 500 g for 10 min, washed once in PBS, and resuspended in 5 ml ofLDM. Aliquots of 600 Ml (2.4 X 106 cells) were added to each of four scintillation vials that contained 5.4 ml of LDM and a small stir bar. Incubations were started as indicated in the figure legend by the addition of 1251-labeled lipoprotein (24-87 Ml vol) and continued at 370C with stirring. At various times, 700-Ml aliquots were removed into l-ml capacity microfuge tubes on ice and were centrifuged at 12,000 rpm for 5 min. To the supernatants, 20 Ml of bovine serum albumin (20 mg/ml) followed by 700 Ml of 20% trichloroacetic acid were added. The suspensions were vortexed, left on ice for not <30 min, and centrifuged at 10,000 g for 10 min. The supernatants were transferred to a fresh tube and S Ml of 40% KI and 50 Ml of 30% H202 were added. The solutions were extracted with 0.7 ml of chloroform and the upper aqueous layer was counted for radioactivity in a y-counter.
Synthesis ofcholesterolfrom ["Clacetate. HTC cells grown in either complete medium or LDM for 20 h were harvested and resuspended in 20 ml of fresh medium, and the cell number was counted. Aliquots containing -1.3 X 10' cells were transferred to sterile Gibco (Gibco Laboratories) culture flasks (100-ml capacity with stirring bar), lipoproteins sterilized by passage through a millipore filter were added (0.5-2.0 ml), and the volume was made up to 25 ml by the addition of the appropriate medium. The flasks were closed and incubated with stirring for 2-4 h at 37°C and then ['4C]acetate (specific activity 2 MCi/Mmol) was added to give a final concentration of 0.2 mM. Incubation was continued for 7 h. The cell numbers were counted and then 40 ml of 95% ethanol, 6.5 ml of 33% KOH, 1 mg ofcarrier cholesterol in ethanol, and 36,000 cpm of 3H-cholesterol as internal standard were added to each flask. After standing overnight at 4°C, the sealed samples were incubated at 90°C for 3 h, cooled, and then extracted three times with 30 ml of petroleum ether (boiling point 30-60°C). The pooled ether extracts were washed with 10 ml of 0.1 N KOH and the washed ether phase dried down to -0.5 ml under a stream of nitrogen. The ether extracts were plated on silica gel H thin layer chromatography plates that were developed with benzene/ethyl acetate (4:1) (36). The cholesterol (0.3 Rf) was visualized by iodine vapor and after decolorization the cholesterol band was scraped from the plate and counted in 10 ml of Aquasol liquid scintillation fluid. Conversion of [14Clacetate to cholesterol is expressed as cpm in cholesterol per 7-h incubation per 107 cells after correction for losses using the 3H-cholesterol internal standard. Cells were counted both at the beginning of the incubation period and at the end ofthe incubations. Because cell number increased during this period the average cell number was used in the calculations.
Growth oftumors in vivo. HTC cells were grown in complete medium as detailed above. 300-ml batches of cells (4-6 X I05 cells/ml) were harvested by centrifugation, washed once in sterile PBS, and resuspended in 2. Preparation ofcell membranes. (a) HTC cell membranes. Membranes were prepared and lipoprotein binding studies to them were carried out by a modification of the method of Basu et al. (37) . Actively growing HTC cells in 300-ml batches (3-6 X 10' cells/ml) were harvested by centrifugation at 100 g for 5 min. They were washed once by resuspension in 50 ml sterile Dulbecco's medium followed by centrifugation. They were resuspended in 7.5 ml hypotonic buffer at 4VC ( and after 10 min were homogenized first with 10 strokes of a motor driven Potter-Elvehjem homogenizer and then with 10 strokes of a hand held Potter-Elvehjem homogenizer. Whole cells were sedimented at 500 g for 5 min, the pellet was resuspended in 7.5 ml hypotonic buffer, and the homogenization and centrifugation were repeated. The supernatants were adjusted to isotonicity by addition of 8.7% NaCl. The sample was centrifuged at 105,000 g for 30 min to give the cell membrane pellet. This pellet was resuspended in 0.5 ml isotonic buffer, homogenized by three strokes in a ground glass homogenizer, and 200 /l were transferred into each of four Airfuge tubes (Beckman Instruments Inc.). Centrifugation at 29 psi in an Airfuge (Beckman Instruments Inc.) for 10 min gave the final pellet. After removal of the supernatant it was stored frozen until assayed for lipoprotein binding activity.
(b) Liver and tumor cell membranes. Rats were anesthetized with ether, samples of blood were withdrawn from the abdominal aorta, and then 2-3-g samples of freshly excised liver or tumor tissue were added to 8-10 ml of buffer (10 mM Tris/HCl, pH 7.4, 150 mM NaCl, 1 mM CaCl2, and 1 mM PMSF) and homogenized with 10 strokes of a motor driven Potter-Elvehjem homogenizer followed by six strokes with a hand held Potter-Elvehjem homogenizer. The suspension was centrifuged for 10 min at 500 g, the supernatant was respun at 500 g and then the new supernatant was centrifuged at 105,000 g for 30 min. The membrane pellet was resuspended in 8 ml of buffer, homogenized with five strokes of a Dounce homogenizer, and recentrifuged at 105,000 g for 20 min. The pellet was resuspended in 1.0 ml of buffer (without PMSF) and 200-IAI aliquots were transferred to airfuge tubes for centrifugation at 29 psi in an airfuge (Beckman Instruments Inc.) for 10 min. After removal of the supernatant the pellet samples were stored frozen until assayed.
Assay of lipoprotein binding to cell membranes. Aliquots of cell membranes from liver, intramuscular tumor, subcutaneous tumor, or HTC cells containing 1.6-4 mg protein were resuspended in 200 !sl buffer (10 mM Tris/HCl, pH 7.5, 50 mM NaCl, and 1 mM CaCl2) by passage 10 times through a 27-gauge needle. Protein content was determined on 1-, 2-, or 5-i1 samples using a micro method based on that of Lowry et al. (38) Binding and internalization ofrat chylomicron remnants by HTC cells. Binding of '25I-remnants to HTC cells at 370C is illustrated in Fig. I with 251I-remnants in Fig. I B (data not shown) .
Binding and metabolism ofhuman LDL by HTC cells. Since remnants that contain apo E can bind to both LDL (B,E) receptors and remnant (E) receptors it was important to further characterize the specificity of the receptor. For this purpose, studies were undertaken initially using human LDL. It is known that human LDL binds to the rat fibroblast LDL receptor, but that it does so with a lower affinity (41, 42) . Studies presented below compare some aspects of human and rat LDL metabolism by HTC cells and confirm the fact that although the use of human LDL may underestimate the affinity of HTC cell LDL receptors, the binding qualitatively reflects that of rat LDL.
The binding pattern to HTC cells observed with human LDL was different from that observed with remnants (Fig. 2) . Much higher concentrations of LDL than of remnants were required to achieve measurable specific binding at 40C. At a concentration of 200 ,g LDL protein/ml, 20 ng/ 106 cells were bound (Fig. 2 A) . The binding obtained with human LDL at 370C was threefold higher (n = 5) than that observed at 40C (Fig. 2 B) . Presumably this was due to the presence of both internalized and partially degraded LDL as well as of surface bound LDL. Another contrast between LDL and remnant binding was observed with EDTA. At 4VC, EDTA was not as effective in reducing LDL binding as a 20-fold excess of unlabeled lipoprotein, which suggests that some Ca++ independent binding was being measured. In the experiments performed at 37°C, the nonspecific binding as determined using either EDTA or a 20-fold excess of unlabeled LDL gave very similar results, which was in contrast to what was observed at 4°C. Taken together, these data suggest that HTC cells also express a receptor that specifically recognizes LDL, albeit with a lower affinity than for remnants.
Competition ofhuman LDL and rat chylomicron remnants for the lipoprotein receptor(s) present on the HTC cell. Because HTC cells bound both remnants and LDL specifically, it was Competitive binding studies at 4°C are shown in Fig. 3 . Binding of 2.6 Mg '251-remnants/ml is illustrated alone and in the presence of an excess of either nonradioactive remnants, human LDL, or rat HDLC (a lipoprotein that is enriched in apo E) (Fig. 3  A) (Fig. 3 B) . Thus, remnants were far more effective in competing for LDL binding than was LDL itselfon a total protein basis. Taken together, these results suggest that remnants and LDL share at least one recognition site, although there may be a second remnant-specific site as well.
Lipoprotein binding and metabolism by cells grown in LDM. The data presented thus far were obtained with cells grown in complete medium that contained 10% calf serum. Because it has been shown that other cell types express more receptors for LDL when they are grown in LDM (43), the binding of lipoproteins to HTC cells grown in LDM was investigated. The cholesterol content of this medium was only 2.6% that of the complete medium. In addition, the HTC cells were grown for remnants. HTC cells were grown in complete medium and harvested as detailed in the legend to Fig. 1 (Fig. 6  A) . These characteristics are shared with human LDL (Fig. 5) . The affinity for rat LDL was between 1.5-and 5-fold greater than for human LDL, depending upon the growth conditions' ofthe cells. This is consistent with reports from other laboratories using fibroblasts (41, 42) , although the magnitude of the difference observed here was somewhat less than reported.
In addition, the metabolism of two types of rat VLDL by these cells was studied. VLDL from normal fed rats displayed saturable specific uptake that increased about fivefold when cells were grown in LDM with compactin (Fig. 6 B) . VLDL from rats fed an atherogenic diet (32) exhibited saturable specific uptake that increased 1.8-fold when cells were grown in LDM with compactin and had a I10-fold higher affinity compared with VLDL from rats fed a normal diet (Fig. 6 C) (Fig. 8) . The In contrast, human LDL only partially reduced the cholesterol synthetic rate of cells grown in LDM and did not prevent the rise induced when cells were transferred from complete to LDM. These findings are consistent with the binding data and confirm the concept that the amount of cholesterol to which the HTC cells are exposed is not per se the crucial factor in regulating cholesterol biosynthesis, but rather it is the ability of the cell to bind and transport the particular lipoprotein particle involved that is important. When either remnants (line 9) or human LDL (line 10) were added at the highest concentrations used in the previous experiments to HTC cells grown and resuspended in complete medium, there was no suppression of [I4Clacetate incorporation into cholesterol to a level below that seen in cells grown in complete medium (line 1). The same was true when the entire lipoprotein-enriched fraction derived from the upper layer of calf serum (density 1.21) was used, even though it contained 2.5 times the cholesterol content of complete medium (line 1 1). Two possibilities exist to explain this failure to suppress cholesterol synthesis to a level below the base line that was expressed by culture in complete medium. Either the cells simply cannot lower their rate of synthesis any further, which would constitute an abnormality of the intracellular mechanism for feedback inhibition, or the number of receptors expressed in the presence of serum is inadequate to transport sufficient cholesterol in chylomicron remnants to suppress synthesis further. To distinguish between these possibilities, the abnormal VLDL from hypercholesterolemic rats were used. These lipoproteins contain substantially more cholesterol per particle than do chylomicron remnants (32, 34) Comparison of remnant binding to cell membranes from hepatomas and normal liver. Based on the above data, the hypothesis that the deletion of feedback inhibition seen in hepatomas in vivo is due to a diminished ability to transport chylomicron remnants as compared with normal liver, continued to be plausible. To test whether there were fewer receptors expressed on hepatomas than on normal liver in vivo, cell membranes were prepared from normal livers, livers of rats bearing hepatomas, hepatomas that had been implanted intramuscularly or subcutaneously, and hepatoma cells grown in vitro. The ability of each of these preparations to specifically bind chylomicron remnants was measured. The assay was similar to that reported by Kovanen et al. (45) and used by Hui et al. (46) . There was no significant difference in binding between membranes of liver from normal rats and the liver of tumor-bearing animals (Fig.  9) . However, the membranes from tumors themselves bound significantly fewer remnants than did either liver preparation (P < 0.001). The membranes from intramuscularly grown tumors bound slightly fewer remnants than those from tumors grown subcutaneously in the same animal. Membranes from the hepatoma cells that had been grown in vitro bound significantly fewer remnants than those from either normal livers or subcutaneously grown tumors. They also bound fewer remnants than intramuscularly grown tumors, but this difference was not statistically significant. Maximal binding to membranes from intramuscularly grown tumors was -30% of that to normal liver. No significant differences in binding affinities, as determined by the slopes of the Scatchard plots, were noted (Fig. 9 B) .
These data support the concept that hepatomas express substantially fewer receptors capable of binding chylomicron remnants than does normal liver. When considered along with the in vitro experiments, these data add strong support to the hypothesis that the lack of feedback inhibition in hepatomas is due at least in part to a diminished capacity of the tumor to transport lipoproteins of dietary origin as compared with normal liver.
Discussion
Cholesterol is an essential component of all mammalian cell membranes and, as such, regulation of its synthesis and metabolism is ofprime importance for cellular growth and function. The demonstration of loss of regulation of cholesterol biosynthesis by dietary cholesterol in a variety of liver neoplasms (14- 18) led to the hypothesis that this regulatory defect was associated with the etiology or pathogenesis of the malignant state (15) . Thus, it became important to identify precisely which step in the regulatory pathway of cholesterol metabolism was aberrant.
Evidence has been provided that many of the intracellular events in the regulation of cholesterol biosynthesis are intact in these cells (22, 25) , and that uptake of intragastrically administered cholesterol by tumors was less than by liver (23) . Ac Having demonstrated that functional lipoprotein receptors are expressed in vitro, it became important to compare the number of receptors expressed by hepatoma cells in vitro with that expressed in vivo, and to compare this with the number of receptors expressed by normal liver. To do this, the binding of chylomicron remnants to cell membranes was studied. Consistent with our hypothesis, the binding ofchylomicron remnants to liver membranes from either normal or tumor-bearing animals was several fold greater than that to tumor membranes. Although it is not certain whether this is due to a reduction or a complete absence of remnant receptors, a difference of this magnitude should significantly lower the ability of tumors to transport chylomicron remnants in vivo as compared with normal liver.
There were some differences in binding among various HTC cell preparations. Membranes from subcutaneously grown tumors had a greater binding capacity than those from in vitro grown hepatoma cells, while membranes from tumors grown intramuscularly were intermediate. This result suggests that the expression of lipoprotein receptors by a tumor cell can be regulated by its environment. This is consistent with the in vitro demonstration that the number of receptors could be increased by growing the cells in LDM with compactin.
From all of the above findings it is clear that hepatomas do express lipoprotein receptors. We postulate that a relative lack of lipoprotein receptors expressed by hepatomas in comparison with those on normal liver explains why hepatoma cells in vivo may not compete efficiently with normal liver for the remnants in the circulation after a cholesterol-containing meal, and therefore may explain why the tumors exhibit an apparent lack of feedback inhibition of cholesterol synthesis.
